SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,247 | -25.4% | 2,953 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $13,731 | +0.6% | 2,953 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $13,643 | -43.4% | 2,953 | -0.9% | 0.00% | 0.0% |
| Q4 2022 | $24,086 | +45.6% | 2,981 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $16,545 | +742.4% | 2,981 | +690.7% | 0.00% | – |
| Q2 2022 | $1,964 | -91.9% | 377 | -87.2% | 0.00% | -100.0% |
| Q1 2022 | $24,224 | -83.4% | 2,947 | -70.0% | 0.00% | -50.0% |
| Q4 2021 | $146,315 | -39.1% | 9,833 | -22.6% | 0.00% | -33.3% |
| Q3 2021 | $240,092 | +7.3% | 12,710 | +5.6% | 0.00% | 0.0% |
| Q2 2021 | $223,656 | +13.8% | 12,031 | +39.3% | 0.00% | 0.0% |
| Q1 2021 | $196,601 | +4.8% | 8,638 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $187,531 | +116.0% | 8,638 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $86,812 | – | 8,638 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $27,149,000 | 17.55% |
| Samsara BioCapital, LLC | 1,675,579 | $24,933,000 | 4.84% |
| AJU IB Investment Co., Ltd. | 175,000 | $2,604,000 | 3.63% |
| First Light Asset Management, LLC | 2,246,588 | $33,429,000 | 2.39% |
| Opaleye Management Inc. | 680,000 | $10,118,000 | 2.15% |
| FRAZIER MANAGEMENT LLC | 1,776,479 | $26,434,000 | 2.04% |
| Connective Portfolio Management, LLC | 35,000 | $527,000 | 0.93% |
| Parkman Healthcare Partners LLC | 221,219 | $3,292,000 | 0.73% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,437,795 | $36,274,000 | 0.70% |
| Eventide Asset Management | 2,708,975 | $40,310,000 | 0.52% |